Table 2 Self-reported vascular comorbidies among migraine patients by triptan use and among controls in 2012
From: Stroke and cardiovascular risk factors among working-aged Finnish migraineurs
Migraine patients | Controls | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Not used triptans | Used triptans | All | |||||||
n | % | n | % | n | % | n | % | p-value | |
Hypertension | 237 | 24.3 | 83 | 16.0 | 320 | 21.3 | 462 | 15.5 | < 0.001 |
High cholesterol value | 415 | 42.4 | 160 | 30.9 | 575 | 38.2 | 991 | 33.0 | < 0.001 |
Diabetes | 81 | 8.3 | 25 | 4.8 | 106 | 7.0 | 173 | 5.8 | 0.073 |
Myocardial infarction | 19 | 2.0 | 3 | 0.6 | 22 | 1.5 | 35 | 1.2 | 0.333 |
Angina pectoris | 37 | 3.8 | 4 | 0.8 | 41 | 2.7 | 57 | 1.9 | 0.057 |
Stroke | 14 | 1.4 | 7 | 1.3 | 21 | 1.4 | 14 | 0.5 | < 0.001 |
disorder | 51 | 5.2 | 16 | 3.1 | 67 | 4.5 | 51 | 1.7 | < 0.001 |